Marshall Edwards (MSHL) NV-128, a Novel mTOR Inhibitor, Demonstrates Good Safety Profile and High Anti-Cancer Activity In Vivo
Tweet Send to a Friend
Marshall Edwards, Inc. (NASDAQ: MSHL) released data demonstrating that the efficacy of NV-128 in animal xenograft ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
